Literature DB >> 23139062

Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.

B S Al-Alao1, D S O'Callaghan, K Gately, S Nicholson, L E Coate, F O'Connell, E McGovern, K J O'Byrne, V K Young.   

Abstract

BACKGROUND: Few patients diagnosed with lung cancer are still alive 5 years after diagnosis. The aim of the current study was to conduct a 10-year review of a consecutive series of patients undergoing curative-intent surgical resection at the largest tertiary referral centre to identify prognostic factors.
METHODS: Case records of all patients operated on for lung cancer between 1998 and 2008 were reviewed. The clinical features and outcomes of all patients with non-small cell lung cancer (NSCLC) stage I-IV were recorded.
RESULTS: A total of 654 patients underwent surgical resection with curative intent during the study period. Median overall survival for the entire cohort was 37 months. The median age at operation was 66 years, with males accounting for 62.7 %. Squamous cell type was the most common histological subtype, and lobectomies were performed in 76.5 % of surgical resections. Pneumonectomy rates decreased significantly in the latter half of the study (25 vs. 16.3 %), while sub-anatomical resection more than doubled (2 vs. 5 %) (p < 0.005). Clinico-pathological characteristics associated with improved survival by univariate analysis include younger age, female sex, smaller tumour size, smoking status, lobectomy, lower T and N status and less advanced pathological stage. Age, gender, smoking status and tumour size, as well as T and N descriptors have emerged as independent prognostic factors by multivariate analysis.
CONCLUSION: We identified several factors that predicted outcome for NSCLC patients undergoing curative-intent surgical resection. Survival rates in our series are comparable to those reported from other thoracic surgery centres.

Entities:  

Mesh:

Year:  2012        PMID: 23139062     DOI: 10.1007/s11845-012-0863-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  24 in total

1.  The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer.

Authors:  Antonio E Martin-Ucar; David A Waller; Jane L Atkins; Daniel Swinson; Ken J O'Byrne; Mick D Peake
Journal:  Lung Cancer       Date:  2004-11       Impact factor: 5.705

Review 2.  Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Authors:  Heather A Wakelee; Joan H Schiller; David R Gandara
Journal:  Clin Lung Cancer       Date:  2006-07       Impact factor: 4.785

3.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

Review 4.  Epidemiology of lung cancer.

Authors:  K E Osann
Journal:  Curr Opin Pulm Med       Date:  1998-07       Impact factor: 3.155

5.  Impact of filter cigarette smoking on lung cancer histology.

Authors:  S D Stellman; J E Muscat; D Hoffmann; E L Wynder
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

6.  Survival after resection for primary lung cancer: a population based study of 3211 resected patients.

Authors:  T-E Strand; H Rostad; B Møller; J Norstein
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

7.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

8.  Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.

Authors:  Ayesha Bryant; Robert James Cerfolio
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

9.  Cigarette smoking and changes in the histopathology of lung cancer.

Authors:  M J Thun; C A Lally; J T Flannery; E E Calle; W D Flanders; C W Heath
Journal:  J Natl Cancer Inst       Date:  1997-11-05       Impact factor: 13.506

10.  Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

Authors:  S-H Ignatius Ou; Jason A Zell; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

View more
  2 in total

1.  Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.

Authors:  Ji-Chang Han; Xian-Dong Li; Jin Du; Feng Xu; Yu-Ju Wei; Hong-Bing Li; Yi-Jie Zhang
Journal:  World J Surg Oncol       Date:  2015-01-14       Impact factor: 2.754

2.  Trends in the incidence rate of lung cancer by histological type and gender in Sichuan, China, 1995-2015: A single-center retrospective study.

Authors:  Xiaoxuan Zhang; Li Wu; Yong Xu; Benxia Zhang; Xueqian Wu; Yongsheng Wang; Zongguo Pang
Journal:  Thorac Cancer       Date:  2018-03-05       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.